In addition, anti-BCR activation of CD27+ B cells resulted in lower Bcl-2 and Bcl-XL induced levels in CVID patients and even lower in AP-CVID patients and lower Bax and Bim induced levels only in AP-CVID patients (Fig. 5b). This evidence concerns the gene BCL2L11 and common variable immunodeficiency.